St. John's University College of Pharmacy and Health Sciences, Department of Clinical Health Professions, 8000 Utopia Pkwy, 112 St. Albert's Hall, Queens, NY 11439, United States; Bellevue Hospital Center, Department of Pharmacy, 462 First Ave, Hospital Building, 18N7, New York, NY 10016, United States.
Southside Hospital, 301 E Main Street, Bay Shore, NY 11706, United States.
Curr Pharm Teach Learn. 2021 Jun;13(6):628-634. doi: 10.1016/j.cptl.2021.01.045. Epub 2021 Feb 11.
Doctor of pharmacy (PharmD) student anxiety is not well accounted for in the literature. Anxiety carries the potential to cause impairment in functioning, worsen mental health outcomes, and adversely impact cognition, academic performance, and professionalism. The purpose of this study was to characterize anxiety among PharmD students in their first through fourth professional years. Secondary aims were to compare the prevalence of clinically significant anxiety and severity of anxiety among classes.
A cross-sectional, observational analysis was performed surveying 198 pharmacy students completing professional coursework. A survey shared via social media containing the Zung Self-Anxiety Scale and general demographic questions was distributed to pharmacy students to assess the prevalence and severity of anxiety in first through fourth professional year students. Clinically significant anxiety was defined as a raw score ≥ 36. A one-way analysis of variance was performed to compare the means of all classes and Tukey's honestly significant differences test was performed to evaluate for statistical differences between individual classes.
Clinically significant anxiety was evident in 65% of respondents. The second professional year class reported the highest rate of anxiety with 84% meeting the threshold for clinically significant anxiety. The fourth professional year class reported the lowest rates with 51% reporting clinically significant anxiety.
Anxiety is prevalent in pharmacy students with higher levels of anxiety observed in earlier years. This work highlights opportunities to expand student mental health resources. Further studies are warranted to identify factors contributing to pharmacy student anxiety.
药剂学博士（PharmD）学生的焦虑在文献中并未得到充分说明。焦虑有可能导致功能障碍，恶化心理健康状况，并对认知、学业成绩和专业精神产生不利影响。本研究的目的是描述 PharmD 学生在第一至第四专业年的焦虑情况。次要目的是比较各班级中临床显著焦虑和焦虑严重程度的患病率。
采用横断面、观察性分析方法，对 198 名正在完成专业课程的药学学生进行调查。通过社交媒体共享包含zung 自我焦虑量表和一般人口统计学问题的调查，以评估第一至第四专业年学生的焦虑发生率和严重程度。临床显著焦虑的定义为原始得分≥36。采用单因素方差分析比较所有班级的平均值，并采用 Tukey Honestly Significant Differences 检验评估各班级之间的统计学差异。
有 65%的受访者出现临床显著焦虑。第二年班级报告的焦虑率最高，84%达到临床显著焦虑的阈值。第四年班级报告的焦虑率最低，为 51%。
焦虑在药学学生中普遍存在，早期阶段的焦虑水平更高。这项工作强调了扩大学生心理健康资源的机会。需要进一步的研究来确定导致药学学生焦虑的因素。
